U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
Botensilimab
USAN   INN  
Official Name English
botensilimab [INN]
Common Name English
Botensilimab [WHO-DD]
Common Name English
Immunoglobulin G1 [240-aspartic acid,331-leucine,333-glutamic acid,de-C-terminal-lysine], anti-(human cytotoxic T-lymphocyte-associated protein 4) (human monoclonal AGEN1181 γ1-chain), disulfide with human monoclonal AGEN1181 κ-chain, dimer
Common Name English
AGEN1181
Code English
AGEN-1181
Code English
Immunoglobulin G1-kappa, anti-[Homo sapiens CTLA4 (cytotoxic T-lymphocyte associated protein 4, CD152)], Homo sapiens monoclonal antibody; gamma1 heavy chain Homo sapiens (1-447) [VH (Homo sapiens IGHV3-21*01 (99.0%) -(IGHD) - IGHJ3*02 (92.9%) M123>L (11
Common Name English
BOTENSILIMAB [USAN]
Common Name English
Code System Code Type Description
FDA UNII
1Z5YC3ME5N
Created by admin on Sat Dec 16 15:08:08 GMT 2023 , Edited by admin on Sat Dec 16 15:08:08 GMT 2023
PRIMARY
INN
11659
Created by admin on Sat Dec 16 15:08:08 GMT 2023 , Edited by admin on Sat Dec 16 15:08:08 GMT 2023
PRIMARY INN
CAS
2408310-37-0
Created by admin on Sat Dec 16 15:08:08 GMT 2023 , Edited by admin on Sat Dec 16 15:08:08 GMT 2023
PRIMARY
USAN
KL-157
Created by admin on Sat Dec 16 15:08:08 GMT 2023 , Edited by admin on Sat Dec 16 15:08:08 GMT 2023
PRIMARY
NCI_THESAURUS
C158557
Created by admin on Sat Dec 16 15:08:08 GMT 2023 , Edited by admin on Sat Dec 16 15:08:08 GMT 2023
PRIMARY
SUBSTANCE RECORD
Botensilimab
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966